Raghu Ram Achar | Nanotechnology in Medicine and Healthcare | Emerging Nanotech Leader Award

Published on by Nano Technology

Dr. Raghu Ram Achar | Nanotechnology in Medicine and Healthcare | Emerging Nanotech Leader Award

Dean, Internal Quality Assurance Cell (IQAC) | Mahayogi Gorakhnath University | India 

Dr. Raghu Ram Achar is an accomplished researcher with a strong publication-driven profile in biochemistry, biomedical sciences, and interdisciplinary life science research. His scholarly output comprises 114 research documents indexed in major databases, reflecting consistent contributions through original research articles, high-quality reviews, book chapters, books, and patents. According to Google Scholar, his work has received 1,342 citations, with an h-index of 19 and an i10-index of 36, demonstrating both sustained productivity and significant academic impact. His research spans enzymology, nanobiotechnology, tissue engineering, cancer biology, mitochondrial research, wound healing, bioinformatics, and computational drug discovery, with publications appearing in high-impact, peer-reviewed international journals. He has actively contributed to funded research projects, interdisciplinary R&D initiatives, innovation-driven studies, and translational research outcomes. His profile is further strengthened by research supervision, peer-review services for reputed journals, editorial and conference roles, and recognized scholarly contributions that collectively position him as a credible and impactful contributor to contemporary biomedical and life sciences research.

Citation Metrics (Google Scholar)

2000

1500

1000

500

0

Citations
1342

Documents
114

h-index
19

i10index
36

Citations

Documents

h-index

i10-index

View Scopus Profile  View ORCID Profile  View Google Scholar  View ResearchGate  View Sci Profiles  View Web Of Science  View Loop Profile  View Scilit Profile  View ScholarGPS

Featured Publications

Zhongtao Zhang | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Nano Technology

Prof. Dr. Zhongtao Zhang | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Laboratory Director | The Affiliated Taian City Central Hospital of Qingdao University | China

Prof. Dr. Zhongtao Zhang is an accomplished researcher in pharmaceutics and translational pharmaceutical sciences, with a strong focus on advanced drug delivery systems, nano-enabled therapeutics, and precision medicine approaches. His research integrates natural medicinal chemistry, pharmaceutical engineering, and tumor-targeted intervention strategies to address critical challenges in disease treatment and drug bioavailability. He has authored 26 scholarly documents indexed in Scopus, achieving 673 citations and an h-index of 14, reflecting the growing impact and recognition of his work. His publications appear in high-impact international journals such as ACS Nano, Chemical Engineering Journal, Materials Today Bio, and Analytical Chemistry, contributing significantly to nanomedicine, biomaterials, and pharmaceutical innovation. Prof. Dr. Zhongtao Zhang has led multiple competitive research projects supported by national and regional funding agencies and holds several national invention patents, demonstrating strong translational and innovation outcomes. His research contributions continue to advance pharmaceutics, interdisciplinary nanotechnology applications, and clinically oriented pharmaceutical R&D.

Citation Metrics (Scopus)

800

600

400

200

0

Citations
673

Documents
26

h-index
14

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Fang Wang | Nanomaterials for Medicine | Research Excellence Award

Published on by Nano Technology

Assoc. Prof. Dr. Fang Wang | Nanomaterials for Medicine | Research Excellence Award

China University of Petroleum | China

Assoc. Prof. Dr. Fang Wang is a highly cited researcher with significant contributions to nanotechnology and nanomedicine, reflected by 2,363 Scopus citations across 138 scholarly documents and an h-index of 27. Her research focuses on the design of multifunctional nanoplatforms for precision cancer therapy, integrating DNA nanotechnology, inorganic heterojunctions, and bioresponsive systems. She has made notable advances in targeted drug delivery, photothermal, photodynamic, chemodynamic, and synergistic chemo-therapeutic strategies using programmable nanocomplexes. Her work emphasizes structure–function relationships, catalytic enhancement, and light–matter interactions to achieve high therapeutic efficacy with minimal off-target effects. Assoc. Prof. Dr. Fang Wang’s research outcomes have been published in high-impact international journals, contributing to translational nanomedicine and advanced therapeutic design. She has actively contributed to interdisciplinary R&D, innovation-driven nanomaterial development, peer-review activities, and editorial and conference-related scholarly services, earning recognition for advancing next-generation smart nanotherapeutics.

Citation Metrics (Scopus)

2500

2000

1500

1000

500

0

Citations
2363

Documents
138

h-index
27

Citations

Documents

h-index

View Scopus Profile

Featured Publications


Manganese-doped CeO2 nanoparticles with phosphatase-like activity for dual-mode detection of aluminum ions
– Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2025 | Citations: 2

Sofia Mares Bou | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Nano Technology

Ms. Sofia Mares Bou | Nanotechnology in Medicine and Healthcare | Research Excellence Award

PhD Student | Centre for Biomaterials and Tissue Engineering (CBIT) – Universitat Politècnica de València (UPV) | Spain

Ms. Sofia Mares Bou is a biomedical engineer with focused research contributions in biomaterials and tissue engineering, emphasizing translational solutions for drug delivery and regenerative medicine. Her scholarly work includes a peer-reviewed journal article in Polymers on core–shell polyvinyl alcohol electrospun microfibers for controlled drug delivery, reflecting expertise in electrospinning, polymeric biomaterials, and therapeutic release systems. She has also presented nationally recognized research on injectable, biomimetic hydrogels for 3D hepatic culture models and hepatotoxicity assessment, contributing to high-throughput in vitro platforms. Ms. Sofia Mares Bou has participated in competitive, publicly funded R&D projects addressing ocular implants for postoperative drug delivery and bioengineered hydrogels with growth-factor presentation. Her research achievements include an award at a national biomedical engineering congress. With Scopus-indexed publications 2, citations 15, and an h-index of 1, her work demonstrates early but impactful contributions to advanced biomaterials, controlled drug delivery, and tissue regeneration research.

Citation Metrics (Scopus)

20

15

10

5

0

Citations
15

Documents
2

h-index
1

Citations

Documents

h-index

View Scopus Profile   View ORCID Profile   View Sci Profiles

Featured Publications

Shabnam Anjum | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Published on by Nano Technology

Dr. Shabnam Anjum | Nanotechnology in Medicine and Healthcare | Research Excellence Award

Post-Doctorate | Shenzhen University | India

Dr. Shabnam Anjum is a postdoctoral researcher at Shenzhen University with a strong research footprint in biomaterials, nanofibrous scaffolds, extracellular vesicles, and regenerative medicine. Her work focuses extensively on the design, fabrication, and optimization of nanofibers, nanoparticles, microspheres, and hydrogels for tissue regeneration, particularly targeting bone, tendon, and ligament repair. She has contributed significantly to the advancement of electrospinning-based nanofibrous scaffolds, developing bioinspired core–shell systems, multifunctional drug-delivery constructs, and biomimetic matrices capable of modulating osteogenic and osteoclastic activity. Her publications in high-impact journals, including ACS Nano, Materials Today Bio, Frontiers in Bioengineering and Biotechnology, International Journal of Biological Macromolecules, and International Journal of Molecular Sciences, highlight her expertise in biomaterials, stem cell–derived extracellular vesicles, nanostructured drug-delivery systems, and regenerative therapeutics. She has authored influential review articles and innovative research papers demonstrating optimized electrospinning strategies, bioactive scaffold architectures, and decellularized matrix-based regenerative platforms. Her published findings collectively record 250 Scopus citations, 9 documents, and an h-index of 7. Dr. Shabnam Anjum’s emerging research pipeline includes cutting-edge studies on extracellular vesicle engineering, spatiotemporal therapeutic delivery, and osteoporotic bone regeneration. Her technical strengths span electrospinning, nanoparticle synthesis, advanced material characterization, microCT analysis, western blotting, qPCR, flow cytometry, and comprehensive biological evaluations. She has presented her research at prestigious scientific events such as the Chinese Biomaterials Conference and has actively engaged in global scientific webinars covering cancer research, stem cell biology, and precision medicine. She has also contributed to the scientific community through participation in specialized training programs on nanomaterials, animal experimentation, and polymer processing. Her research has been recognized through notable scholarships and academic distinctions, reflecting her dedication to innovative biomaterial development and regenerative therapy. Dr. Shabnam Anjum’s contributions continue to support advancements in nanotechnology-enabled regenerative medicine, positioning her as a promising researcher in the fields of tissue engineering, biomaterials design, and therapeutic nanotechnology.

Profiles: Scopus | Google Scholar | ResearchGate | Sci Profiles | Scilit | Loop

Featured Publications

1. Anjum, S., Rahman, F., Pandey, P., Arya, D. K., Alam, M., Rajinikanth, P. S., & Ao, Q. (2022). Electrospun biomimetic nanofibrous scaffolds: A promising prospect for bone tissue engineering and regenerative medicine. International Journal of Molecular Sciences, 23(16), 9206. https://doi.org/10.3390/ijms23169206

2. Kanaujiya, S., Arya, D. K., Pandey, P., Singh, S., Pandey, G., Anjum, S., … Rajinikanth, P. S. (2024). Resveratrol-ampicillin dual-drug loaded polyvinylpyrrolidone/polyvinyl alcohol biomimic electrospun nanofiber enriched with collagen for efficient burn wound repair. International Journal of Nanomedicine, 19, 5397–5418. https://doi.org/10.2147/IJN.S464046

3. Anjum, S., Wang, Y., Xin, Y., Li, X., Li, T., Zhang, H., Quan, L., Li, Y., Arya, D. K., … Ao, Q. (2024). Bioinspired core-shell nanofiber drug-delivery system modulates osteogenic and osteoclast activity for bone tissue regeneration. Materials Today Bio, 26, 101088. https://doi.org/10.1016/j.mtbio.2024.101088

4. Anjum, S., Li, T., Saeed, M., & Ao, Q. (2024). Exploring polysaccharide and protein-enriched decellularized matrix scaffolds for tendon and ligament repair: A review. International Journal of Biological Macromolecules, 254, 127891. https://doi.org/10.1016/j.ijbiomac.2023.127891

5. Arya, D. K., Deshpande, H., Kumar, A., Chidambaram, K., Pandey, P., Anjum, S., … Pandey, G. (2024). HER-2 receptor and αvβ3 integrin dual-ligand surface-functionalized liposome for metastatic breast cancer therapy. Pharmaceutics, 16(9), 1128. https://doi.org/10.3390/pharmaceutics16091128

David Stejskal | Nanobiotechnology | Best Researcher Award

Published on by Nano Technology

Prof. Dr. David Stejskal | Nanobiotechnology | Best Researcher Award

Professor, MD, PhD, MBA, EuSpLM, Head of the Institute of Laboratory Medicine | University Hospital in Ostrava | Czech Republic

Prof. Dr. David Stejskal, MD, PhD, MBA, EuSpLM, is a distinguished researcher and academic leader in the field of laboratory medicine, clinical biochemistry, and internal medicine. His research primarily focuses on the identification and clinical validation of novel biomarkers relevant to metabolic, cardiovascular, nephrological, and inflammatory diseases. With over 3,767 citations, an h-index of 29 (Scopus), and more than 200 peer-reviewed publications, his scholarly influence spans translational diagnostics and clinical applications in metabolic and endocrine disorders. His most cited works include pioneering studies on fatty acid binding proteins (FABP), chemerin, and FGF23, which have significantly advanced understanding of biomarkers in metabolic syndrome, chronic kidney disease, and cardiovascular risk assessment. Prof. Dr. David Stejskal’s research group has also contributed substantially to the development of novel diagnostic markers for diabetes, obesity, and atherosclerosis, as well as the evaluation of inflammatory and oxidative stress parameters in internal medicine. Beyond journal publications, he has authored and co-authored several scientific books such as Metabolic Diseases of Mass Incidence, Dyslipidemia, and Urolithiasis, alongside chapters in specialized medical encyclopedias. His work has been instrumental in shaping biomarker-based diagnostic strategies across Central Europe. Prof. Dr. David Stejskal has received notable research and organizational recognitions, including the OMICS Award (USA) for excellence in translational medicine and the Czech Society of Clinical Biochemistry Award. As an editorial contributor, reviewer, and conference organizer, he has significantly influenced international collaboration in laboratory and clinical research. His continued focus on biochemical innovation, diagnostic optimization, and translational research highlights his contribution to advancing laboratory medicine and evidence-based clinical diagnostics globally.

Profiles: Scopus | ORCID | ResearchGate | Sci Profiles | Web of Science

Featured Publications

1. Sigutova, R., Evin, L., Kusnierova, P., Svagera, Z., Branny, M., & Vaclavik, J. (2025). Specific microRNAs for heart failure: Reference values in whole blood. Biomedicines, 13(10), 2559. https://doi.org/10.3390/biomedicines13102559

2. Urinovska, R., Sistik, P., Buzga, M., & Stejskal, D. (2024). Fast and easy simultaneous determination of riboflavin, folic acid, all-trans-retinol and α-tocopherol in human serum by LC/MS/MS for bariatric patients. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmae035

3. Johannsen, B., Baumgartner, D., Karpíšek, M., Paust, N., Zengerle, R., & Mitsakakis, K. (2024). Integration of a bead-based immunoassay on a commercial PCR-performing POC device. Proceedings, 2024(097166). https://doi.org/10.3390/proceedings2024097166

4. Johannsen, B., Baumgartner, D., Karpíšek, M., Paust, N., Zengerle, R., & Mitsakakis, K. (2023). Patient stratification for antibiotic prescriptions based on the bound-free phase detection immunoassay of C-reactive protein in serum samples. Biosensors, 13(12), 1009. https://doi.org/10.3390/bios13121009

5. Plášek, J., Lazárová, M., Dodulík, J., Švagera, Z., Všianský, F., & Václavík, J. (2022). Secretoneurin as a novel biomarker of cardiovascular episodes: Are we there yet? A narrative review. Journal of Clinical Medicine, 11(23), 7191. https://doi.org/10.3390/jcm11237191

Fatma Yurt | Nanomedicine | Best Researcher Award

Published on by Nano Technology

Prof. Dr. Fatma Yurt | Nanomedicine | Best Researcher Award

Ege University | Turkey

Prof. Dr. Fatma Yurt is a Professor at the Institute of Nuclear Sciences, Ege University, İzmir, Türkiye, where she serves as Coordinator of the Nuclear Applications Program and has previously directed the Institute. She earned her B.Sc. in Chemistry and her Ph.D. in Nuclear Sciences, both from Ege University, and has become a leading academic and researcher in radiopharmacy, nuclear medicine, pharmaceutical technology, radiation shielding, photodynamic therapy, and imaging of infections and cancers. Her pioneering work bridges fundamental nuclear sciences with translational medical applications, with a particular focus on radiopharmaceuticals, radionuclide diagnostics, and innovative therapeutic strategies for cancer and other diseases. Prof. Yurt has published 133 documents, which have been cited 1,613 times across 1,208 documents, achieving an h-index of 22, reflecting her strong international research impact. Her recent research has explored multifunctional nanomaterials, targeted drug delivery systems, and hybrid therapeutic-imaging platforms that integrate photothermal, photodynamic, and chemotherapeutic effects, underscoring her interdisciplinary approach to advancing nuclear applications in medicine. She has also contributed significantly to the development of novel radiolabeling techniques, biosensing strategies, and in vitro and in vivo evaluation methods, demonstrating a commitment to both basic and applied science. In addition to her extensive research contributions, she is a dedicated educator and mentor, fostering the next generation of scientists while contributing to academic leadership, curriculum development, and international collaborations at Ege University, ensuring the growth and global recognition of nuclear sciences research in Türkiye.

Profile: Scopus | Orcid

Featured Publications

  • Kaya, G., Tunçel, A., Özel, D., Sert, B., Harputlu, E., Ünlü, C. G., Ocakoglu, K., & Yurt, F. (2025). Fucoidan-functionalized molybdenum carbide nanospheres for combined therapy: Photothermal, photodynamic, and chemotherapeutic effects on triple-negative breast cancer cell lines. International Journal of Biological Macromolecules.

  • Özel, D., & Yurt, F. (2025). Synthesis and characterization of manganese-loaded core-shell SPIONs for dual T1/T2 weighted MR imaging applications in breast cancer. Inorganic Chemistry Communications.

  • Özel, D., Tunçel, A., Kaya, G., Sert, B., Yilmaz, O., Aktas, S., Kolatan, H. E., Gokbayrak, Ö., Ünlü, C. G., & Yurt, F. (2025). Targeted therapy for glioblastoma: Synergistic effects of GO/C-TMZ,@, PmAb and magnetic hyperthermia. ACS Applied Bio Materials.

  • Tunçel, A., Sert, B., Özel, D., Kaya, G., Harputlu, E., Ünlü, C. G., Güleç, S., Yurt, F., & Ocakoglu, K. (2025). Enhanced glioblastoma treatment via carbon-coated perovskite nanohybrid: Synergistic effects of targeted chemotherapy and magnetic hyperthermia. Journal of Drug Delivery Science and Technology.

  • Özel, D., Sarıkahya, N. B., Tunçel, A., Nalbantsoy, A., & Yurt, F. (2025). Preparation and biodistribution of [131I]iodoelmalienoside a, a saponin-based adjuvant, in mice. Journal of Radioanalytical and Nuclear Chemistry.

  • Kaya, G., Tunçel, A., Özel, D., Sert, B., Harputlu, E., Ünlü, C. G., Ocakoglu, K., & Yurt, F. (2025). Assessment of Mo₂C@C@Fuc/Mo₂C-MXene@Fuc hybrid structures: Potential for photothermal and photodynamic applications. Surfaces and Interfaces.

  • Sezgin, E., Camgöz, B., & Yurt, F. (2025). Radiation dosimetry in 68Ga-PSMA PET/CT prostate imaging. Journal of Radioanalytical and Nuclear Chemistry.

  • Sert, B., Kaya, G., Çiçek, S., Harputlu, E., Şimşek, T., Tekgül, A., Ünlü, C. G., Yurt, F., & Ocakoglu, K. (2025). Influence of silane coating and graphene oxide integration on the magnetothermal behaviors of La1-xSrxMnO3 nanoparticles. Journal of Magnetism and Magnetic Materials.

Hanghang Liu | Nanomedicine | Women Researcher Award

Published on by Nano Technology

Prof. Dr. Hanghang Liu | Nanomedicine | Women Researcher Award

Assistant Professor at China Three Gorges University | China

Prof. Dr. Hanghang Liu is an accomplished Associate Professor at China Three Gorges University, with expertise in nanomedicine, molecular imaging, and targeted drug delivery. Her academic foundation blends chemistry and preclinical medicine, enabling her to develop multifunctional nanomaterials for the diagnosis and treatment of complex diseases such as Parkinson’s disease and breast cancer. She has made significant research contributions published in high-impact journals. In addition to her research achievements, she actively mentors graduate students in the development of natural product-based nanomedicine, promoting interdisciplinary innovation in biomedical science. Prof. Liu’s work stands at the intersection of fundamental research and clinical translation, making her a leading figure in the advancement of therapeutic nanotechnologies.

Professional Profile

Scopus Profile

Education

Prof. Dr. Hanghang Liu has a strong and interdisciplinary academic foundation in chemistry and biomedical sciences. She began her academic journey at the School of Chemistry and Chemical Engineering, Henan Normal University, where she developed a solid grounding in chemical principles and research methodologies. She then advanced her studies at the Laboratory of Molecular Imaging and Nuclear Medicine at Soochow University, where she completed a doctoral degree in Chemistry with a focus on multifunctional metal nanoprobes for the diagnosis and treatment of breast cancer. Continuing in the same laboratory, she further specialized in preclinical medicine, exploring the application of multifunctional nanomaterials for the treatment of Parkinson’s disease. Her academic path reflects a seamless integration of chemistry, nanotechnology, and translational medicine, which serves as the backbone of her pioneering research in nanomedicine.

Experience

Prof. Dr. Hanghang Liu has cultivated a distinguished career in nanomedicine and molecular imaging through a combination of research, teaching, and mentorship. She currently serves as an Associate Professor at China Three Gorges University, where she leads research efforts in the development and application of natural product-based nanomedicine. In this role, she supervises six master’s students and contributes to the advancement of interdisciplinary research in the Natural Products Research and Utilization Laboratory. Prior to this, she gained valuable experience as a Research Assistant at Soochow University’s Laboratory of Molecular Imaging and Nuclear Medicine, where she was deeply involved in cutting-edge projects related to nanoparticle-based diagnostics and therapeutics for neurodegenerative diseases and cancer. Throughout her professional journey, Prof. Liu has demonstrated a strong commitment to innovation and academic excellence, consistently contributing to high-impact research and nurturing future scientific talent.

Research Interests

Prof. Dr. Hanghang Liu’s research interests lie at the intersection of nanotechnology, molecular imaging, and biomedical applications. She focuses on the design and development of multifunctional nanomaterials for the diagnosis and treatment of neurodegenerative diseases, particularly Parkinson’s disease, and various cancers such as breast cancer. Her work emphasizes the use of metal-based nanoprobes, biomimetic nanoparticles, and natural product-derived nanomedicine to enhance therapeutic efficacy and targeting precision. Additionally, she is interested in the mechanisms of autophagy, oxidative stress modulation, and immune activation through nanoplatforms. Her research aims to bridge fundamental science with clinical application, advancing the field of translational nanomedicine.

Publications

Inhibiting Immune Crosstalk by Modulation of the Intracellular Function and Extracellular Environment of Diseased Microglia to Boost Parkinson’s Disease Therapy

Recent Advance in Sensitive Detection of Demethylase FTO

The Label- and Laser-Free Autocatalytic Nucleic Acid Amplification Reaction for the Sensitive miRNA Detection

Hijacking Endogenous Iron to Amplify Lysosomal-Mitochondrial Cascade Damage for Boosting Anti-Tumor Immunotherapy

Conclusion

Prof. Dr. Hanghang Liu is a highly suitable and deserving candidate for the Research for Women Researcher Award. Her pioneering work in developing multifunctional nanoprobes for the diagnosis and therapy of complex diseases like Parkinson’s and breast cancer showcases her as a forward-thinking and impactful researcher. With continued efforts toward global engagement and outreach, she is well-poised to shape the future of nanomedicine and inspire women in science worldwide.